The pan-HDAC inhibitor trichostatin A acts on human peripheral blood-derived CD4+CD25+Foxp3+ Tregs, reversing their conversion into Th17 cells and increasing Foxp3 expression in healthy controls [79] and in patients with psoriasis [22]. This evidence concerns the gene HDAC9 and psoriasis.